ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
7,931.70
-0.50%
S&P ASX All Technology
3,073.70
-0.79%
Brent Oil
81.60
-0.83%
US Dollar vs AUD
1.50583
0.65%
Bitcoin
68,081.35
-0.11%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. ETFs
  4. USA
  5. AMEX
  6. iShares Core Moderate Allocation ETF (AOM)

  7. iShares Core Moderate Allocation ETF (AOM) News

AOM

Moderate Allocation ETF (AOM)

iShares Core Moderate Allocation ETF
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:AOM
DateTimeSourceHeadlineSymbolCompany
05/09/201221:22ZacksTarget Allocation ETF Investing 101 - ETF News And CommentaryAMEX:AOMiShares Core Moderate Allocation ETF
15/04/201222:50ZacksiShares Launches Multi-Asset, Global Junk Bond ETFs - ETF News And CommentaryAMEX:AOMiShares Core Moderate Allocation ETF
27/10/200600:00PR Newswire (US)Koronis Pharmaceuticals Appoints Stephen Becker, M.D., Chief Medical OfficerASX:AOM
19/09/200622:30PR Newswire (US)Poniard Pharmaceuticals Expands Picoplatin Agreement to Include Exclusive Worldwide Rights and Improved Financial Terms and CondASX:AOM
08/09/200608:11PR Newswire (US)AnorMED shares begin trading on NASDAQASX:AOM
06/09/200600:38PR Newswire (US)AnorMED Board recommends shareholders reject hostile Genzyme offer and not tender sharesASX:AOM
02/09/200608:41PR Newswire (US)AnorMED advises shareholders to take no action on unsolicited takeover bid from Genzyme CorporationASX:AOM
31/08/200601:19PR Newswire (US)Genzyme to Initiate Tender Offer to Acquire AnorMED, Inc.ASX:AOM
30/08/200620:34PR Newswire (US)AnorMED rejects unsolicited approach from GenzymeASX:AOM
29/08/200605:41PR Newswire (US)AnorMED announces NASDAQ listing and filing of shelf registration statementASX:AOM
29/08/200600:00PR Newswire (US)AnorMED announces Annual and Special Meeting of ShareholdersASX:AOM
28/07/200607:05PR Newswire (US)AnorMED reports fiscal 2007 first quarter results and upcoming milestonesASX:AOM
21/06/200607:30PR Newswire (US)AnorMED to present at the Orion Healthcare ConferenceASX:AOM
14/06/200607:05PR Newswire (US)AnorMED provides outlook for fiscal 2007ASX:AOM
10/06/200607:10PR Newswire (US)AnorMed to present at the fifth annual Needham Biotechnology ConferenceASX:AOM
09/06/200607:10PR Newswire (US)AnorMED to present at the Pacific Growth Equities Life Sciences ConferenceASX:AOM
03/06/200610:58PR Newswire (US)AnorMED announces departure of Vice President CommunicationsASX:AOM
30/05/200608:31PR Newswire (US)AnorMED conference call notification - 4th Quarter Fiscal 2006 ResultsASX:AOM
24/05/200618:10PR Newswire (US)AnorMED President and CEO Michael Abrams steps downASX:AOM
22/04/200607:17PR Newswire (US)AnorMED Shareholders Vote Overwhelmingly For New Shareholder-Nominated BoardASX:AOM
13/04/200604:58PR Newswire (US)Special Committee of AnorMED Board Rejects Compromise Slate of 7 MembersASX:AOM
10/04/200612:51PR Newswire (US)Baker refuses previously agreed upon "hybrid" slateASX:AOM
08/04/200610:58PR Newswire (US)AnorMED proposes to negotiate settlement with Baker via neutral third party mediatorASX:AOM
07/04/200613:33PR Newswire (US)AnorMED dissidents fail to justify giving control of AnorMED to Baker GroupASX:AOM
07/04/200609:40PR Newswire (US)AnorMED asks BC Supreme Court to order dissidents to correct information in proxy circularASX:AOM
06/04/200602:59PR Newswire (US)AnorMED dissidents fail to justify giving control of AnorMED to Baker GroupASX:AOM
01/04/200613:06PR Newswire (US)AnorMED to present at the CIBC World Markets Healthcare ConferenceASX:AOM
28/03/200601:24PR Newswire (US)AnorMED conference call notification - AnorMED recommends shareholders reject dissident slate of director nomineesASX:AOM
28/03/200601:06PR Newswire (US)AnorMED Recommends Shareholders Reject Dissident Slate of Director NomineesASX:AOM
21/03/200600:15PR Newswire (US)AnorMED releases statement regarding rejection of the Baker Group proposal & decision to hold special shareholder meetingASX:AOM
 Showing the most relevant articles for your search:AMEX:AOM

Your Recent History

NASDAQ
ABDHSXX
Citigroup Global Markets...
TG
JJEH
JPMorgan ETFS Ireland ICAV
EU
BFCER
Banque Federative du Cre...
USOTC
LQRCF
Black Mammoth Metals (PK)
EU
BOTEM
Republic of Portugal 0.7...
FTSE
E3X402010
FTSEurofirst 300 Consume...
NASDAQ
AACAX
Alpha Alternative Assets...
NASDAQ
ZCJEOX
Summit Peak Ventures Iii
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved